Product Images Pregabalin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Pregabalin NDC 70518-3638 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
MM1 - Pregabalin 25mg 70518 3638 00
This text provides information regarding Pregabalin capsules, each containing 25 mg, with a quantity of 30 capsules. It specifies the prescription-only nature of the medication, lists the NDC number, manufacturing details, storage instructions, and the repackaging information. For specific usage guidelines, it refers to the package insert.*
Figure 7 - pregabalin fig07
Figure 9 - pregabalin fig08
This text provides information on the percentage of patients showing improvement in pain levels based on different doses of Pregabalin and Placebo. The data shows varying levels of improvement at different dose levels, with the 450mg daily dose of Pregabalin demonstrating a higher percentage of patients improved compared to the 300mg dose and Placebo.*
Figure 10 - pregabalin fig09
This text lists the estimated percentage of subjects without LTR (Likely to Recommend) for different groups (Progabain and Placebo) over a period of time (from 0 to 180 days). The table shows the distribution of the percentage of subjects for each group at different time points.*
Figure 11 - pregabalin fig10
This data shows the percentage of subjects that improved from baseline to week 12 using two different treatments: Pregetalin and Placeso. The information is presented in a table format with numbers representing the percent of improvement for each treatment group.*
Figure 12 - pregabalin fig11
This data table shows the percentage of subjects improved from baseline to week 16 in a study comparing the drug Pregabalin to a Placebo. The results indicate that Pregabalin had a higher percentage of improvement compared to Placebo.*
Cockcroft and Gault equation - pregabalin formula
This is a formula for calculating creatinine clearance (CLCT) in patients. It involves subtracting the age in years from 140, then multiplying the result by the weight in kilograms. For female patients, the next step is to multiply the result by 0.85. Finally, this value is multiplied by the serum creatinine level in milligrams per deciliter (mg/dL).*
Chemical Structure - pregabalin str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
